Skip to main content
Clinical Trials/NCT00818116
NCT00818116
Completed
Phase 4

Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric Intraocular Lens (IOL): Postmarket Evaluation

Alcon Research1 site in 1 country34 target enrollmentDecember 2008
ConditionsCataracts

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Cataracts
Sponsor
Alcon Research
Enrollment
34
Locations
1
Primary Endpoint
Uncorrected and Best Corrected Visual Acuities (Near and Distance)
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The objective of this study is to evaluate postoperative visual function in patients implanted bilaterally with the ReSTOR Aspheric Intraocular Lens (IOL).

Registry
clinicaltrials.gov
Start Date
December 2008
End Date
July 2009
Last Updated
15 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Bilateral cataract patients who require natural crystalline lens removal and bilateral Intraocular Lens (IOL) implantation.
  • 50\~75 years of age
  • \<1 Diopter of astigmatism preoperatively (before surgery) as measured by Keratometry readings.

Exclusion Criteria

  • Patients with pre-existing conditions that could skew the results.
  • Any of conditions before and during surgery specified in the product information.

Outcomes

Primary Outcomes

Uncorrected and Best Corrected Visual Acuities (Near and Distance)

Time Frame: 6 Months Following Cataract Surgery

Measurement of uncorrected (without spectacles or other visual corrective devices) and best-corrected (with spectacles or other visual corrective devices)visual acuity at both near and distance. Visual Acuity (VA) is measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better visual acuity.

Study Sites (1)

Loading locations...

Similar Trials